eISSN: 2500-7106 / ISSN: 0123-2576
Register
Login
Medicinay Laboratorio
2023, Volume: 27, Issue:3 : 199-209 doi: 10.36384/01232576.652
Research Article
Intrinsic subtypes of breast cancer and prognostic factors in a reference center in Medellin, Colombia. A descriptive study
Received
July 2, 2023
Revised
July 19, 2023
Accepted
Aug. 1, 2023
Published
Aug. 15, 2023
Abstract
Abstract. Introduction. Among women, breast cancer is the most common cancer in the world. It represents a heterogeneous disease, because the same histopatho logical type can have different biological behavior according to its molecular clas sification, providing prognostic value and as a predictor of response to neoadju vant chemotherapy. The objective of this study was to describe the distribution of intrinsic subtypes of breast cancer, and their association with prognostic factors, as well as the sociodemographic and clinical characteristics of patients at the Clínica Medellín, between 2016 and 2019. Methodology. Descriptive, retrospective study of an institutional database, in the period 2016 to 2019. Demographic and clinical data from medical records were analyzed using descriptive statistics. Results. A total of 468 medical records were included in the study, the median age at diagno sis was 61 years, and 27% (n=131) were under 50 years of age. The most frequent histological type was ductal with 89.1% (n=417), and histological grade 2 was the most frequent with 44% (n=206) of the cases. The most frequent intrinsic subtype was luminal A with 32.7% (n=153), followed by luminal B HER2- with 30.1% (n=141), luminal B HER2+ with 17.3% (n=81), triple negative with 13% (n=61) and, finally, HER2 enriched with 6.8% (n=32). Conclusion. The distribution of the intrinsic sub types of breast cancer in the study population showed that the luminal A subtype was the most frequent, while the triple negative and HER2-enriched subtypes were the least frequent.
Keywords
License
Copyright (c) Medicinay Laboratorio
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Medicinay Laboratorio open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Lupus eritematoso sistémico
211-223
PDF
Impact of Severe Pre-eclampsia and Eclampsia on Fetomaternal Outcomes: A retrospective study
14-17
PDF
Clinical judgment: key in the selection within the "diverse list" of laboratory tests in hemostasis
95-96
PDF
Balance of the last three years: Adaptation and evolution towards a new stage
11-12
PDF
Medicinay Laboratorio journal thumbnail
Volume: 27, Issue:3
Citations
34 Views
56 Downloads
Share this article
Editora Médica Colombiana SA / Universidad de Antioquia
Certified Continuing Medical Education Program (PEMCC)
Email: submission@medicinaylaboratorio.com
Carrera 43C #5-33 Medellín, Colombia 050022
DOI: https://doi.org/10.36384/issn.0123-2576
Open Access Publication
Magazone managed by Biteca